Asthma: What Happens in an Attack

An asthma attack is not one thing going wrong — it is three things going wrong at once in the same small tube. The muscle wrapped around the airway squeezes. The wall underneath it swells. And the lining fills the remaining space with mucus. Watch a bronchiole do all three, and watch the number that matters explode: because resistance to airflow rises with the fourth power of the radius, an airway that narrows by half becomes sixteen times harder to breathe through. That is why a change you could not see on an X-ray can feel like drowning.

Try this: start on Normal, hit Allergen and watch the resistance number jump — then press 💨 Rescue inhaler and watch it fall back to green in seconds. Now switch to Late phase and press the rescue inhaler again. It barely helps. Then go to Severe and watch the wheeze meter fall while everything else gets worse.

The Science in Plain Language

An attack is three problems stacked in the same tube

Ask most people what asthma is and they will say "the airways tighten." That is one third of the answer, and it is the third that reverses most easily — which is exactly why the other two thirds catch people out.

One: the muscle squeezes. Every airway from the trachea down to the smallest bronchiole is wrapped in a spiral of airway smooth muscle. In asthma that muscle is both thicker than normal and twitchier than normal, and when it contracts it narrows the tube from the outside in. This is bronchoconstriction. It can happen in seconds, and it can be undone in minutes by a reliever inhaler.

Two: the wall swells. Underneath the muscle lies the submucosa — a layer packed with small blood vessels, mast cells and, in asthma, eosinophils. Inflammatory signals make those vessels leak plasma into the tissue. The wall becomes waterlogged and thick. Because the airway is tethered in place by the surrounding lung, a thicker wall has nowhere to expand outward, so it expands inward and steals lumen. This is oedema, and it takes hours to build and days to settle. No reliever inhaler touches it.

Three: mucus fills what is left. Goblet cells in the lining multiply and enlarge, and they pour out mucin — chiefly MUC5AC — that is unusually thick and sticky. Meanwhile the cilia that would normally sweep that mucus up and out are damaged and slowed. Mucus therefore accumulates, and in a bad attack it forms actual plugs that seal off whole segments of lung. Post-mortem studies of people who died of asthma have long shown airways occluded by tenacious mucus plugs, and modern CT imaging finds mucus plugging in a substantial share of people with severe asthma even between attacks.

Press the scenario buttons on the animation and watch which of the three moves. In Allergen (early) it is almost all muscle. In Late phase the muscle has partly relaxed but the wall has thickened and the lumen has filled with amber. In Severe all three are maximal at once.

The fourth-power law: why a small narrowing feels catastrophic

This is the single most useful piece of physics in respiratory medicine, and it explains why asthma feels so wildly out of proportion to how little has actually changed.

For smooth flow down a tube, resistance follows Poiseuille's law: resistance is proportional to 1 divided by the radius to the fourth power. Not the radius. Not the radius squared. The fourth power.

Work through what that means. Narrow an airway by 10% — a change you could not see with the naked eye — and resistance rises about 1.5-fold. Narrow it by 20% and resistance roughly doubles. Narrow it by half, and resistance goes up sixteen-fold. Narrow it to a third of its radius and resistance is eighty-one times what it was.

The animation drives its resistance readout directly off this equation, which is why the number climbs so violently when you switch scenarios. In the severe scenario the modelled radius falls to roughly a quarter of baseline and the single-airway resistance figure runs into the hundreds. Hold that number lightly: it is arithmetically correct for one tube, but the lung is not one tube. There are on the order of tens of thousands of small airways arranged in parallel, and parallel resistances add as reciprocals, so total airway resistance in a real severe attack rises by a far more modest multiple. Airways also do not all narrow together — asthma is patchy, which is part of why the disease scatters ventilation so unevenly.

But the intuition survives intact, and it is the intuition that matters: tiny geometric changes produce enormous mechanical consequences. It is also why a small amount of extra swelling or a thin film of mucus — which subtract from the radius of an already narrowed tube — are so much more dangerous than the same amount added to a healthy airway. The fourth power is unforgiving at the bottom of its range.

Early phase and late phase: the attack that comes back

Allergic asthma attacks often come in two waves, and people who only know about the first wave get ambushed by the second.

The early phase starts within minutes. In someone already sensitised, allergen molecules cross-link IgE antibodies sitting on the surface of mast cells in the airway wall. The mast cell degranulates: it dumps preformed histamine and tryptase and rapidly manufactures cysteinyl leukotrienes (LTC₄, LTD₄, LTE₄) and prostaglandin D₂. Those mediators act on receptors on airway smooth muscle and it contracts. Cysteinyl leukotrienes are, gram for gram, among the most powerful bronchoconstrictors known — far more potent than histamine — which is why leukotriene-blocking drugs such as montelukast and zafirlukast have a place in asthma at all. Peak narrowing typically arrives around fifteen to thirty minutes after exposure, and the early phase usually resolves within an hour or two, especially with a reliever inhaler.

Then, in a substantial proportion of people, the late phase arrives — classically four to eight hours after the exposure, sometimes later. This is not a second dose of allergen. It is the arrival of the cells the first wave recruited. Type-2 cytokines — IL-4, IL-5 and IL-13 — have summoned eosinophils out of the bloodstream and into the airway wall. IL-5 is the eosinophil's growth and survival signal; IL-13 drives goblet-cell metaplasia and mucus production. Eosinophils release granule proteins that damage the epithelium. The wall becomes oedematous and cellular, mucus output climbs, and the airway is now narrowed by material that no bronchodilator can relax.

This is the practical reason the late phase is dangerous. Someone has a reaction at four in the afternoon, uses their reliever, feels fine by five, goes to bed — and wakes at two in the morning genuinely unable to breathe, with an inhaler that is no longer working properly. Select Late phase in the animation and then press the rescue inhaler. Watch how little the number moves.

Peak flow and the three zones — how to actually use a meter

A peak-flow meter is a cheap plastic tube that measures the fastest speed you can blow air out, in litres per minute. It is crude, effort-dependent and easy to game — and it is still one of the most useful things a person with asthma can own, because it detects narrowing before you feel it. Many people are poor perceivers of their own airflow obstruction; the meter is not.

How to use it properly: stand up, slide the marker to zero, take the deepest breath you can, seal your lips around the mouthpiece, and blow one short, hard, explosive blast — like blowing out birthday candles, not like a long sigh. Do it three times and record the best of the three, not the average.

The number only means something relative to your personal best, which is the highest reading you can produce when your asthma is well controlled — established over two to three weeks of twice-daily readings, not guessed. Every action plan then divides the range into three:

1. Green zone — 80% or more of personal best. Good control. Carry on with your usual controller treatment.
2. Yellow zone — 50% to 80%. A warning. Something is narrowing. Your action plan usually tells you to use your reliever and, in many plans, to step up your controller treatment. If you keep landing in yellow, your baseline treatment is not enough.
3. Red zone — below 50%. Take your reliever now and get medical help. Do not wait to see how it goes.

Two extra readings that clinicians watch: a peak flow that swings widely between morning and evening (asthma is famously worse in the early hours) points to poorly controlled disease even when individual numbers look acceptable; and a peak flow that drops after work and recovers on holiday is the classic signature of occupational asthma.

Peak flow is a screening instrument, not a diagnosis. Formal diagnosis rests on spirometry, where the key finding is an obstructive pattern — an FEV1/FVC ratio below 0.70 — that improves substantially after a bronchodilator. An increase in FEV1 of at least 12% and 200 mL after a bronchodilator has long been the standard marker of reversibility, and reversibility is what distinguishes asthma from the largely fixed obstruction of COPD.

Reliever vs. controller: two inhalers doing opposite jobs on opposite clocks

Most people with asthma carry two inhalers and are hazy about which is which. The difference is not strength. It is mechanism and timescale, and confusing them is one of the most dangerous mistakes in the whole condition.

The reliever is usually albuterol (called salbutamol outside the United States) — a short-acting beta-2 agonist, or SABA. It binds β₂-adrenergic receptors on airway smooth muscle. Those receptors are coupled to a G-protein that switches on adenylyl cyclase, which makes cyclic AMP, which activates protein kinase A, which drives calcium out of the muscle cell and relaxes it. The muscle lets go. Onset is around five minutes, peak effect within the first hour, and the effect lasts roughly four to six hours. It does nothing whatsoever to swelling, to eosinophils, or to mucus — and it does nothing to prevent the next attack.

The controller is an inhaled corticosteroid (ICS) — beclometasone, budesonide, fluticasone, ciclesonide, mometasone. Steroid molecules cross into the cell, bind the glucocorticoid receptor, and change which genes get transcribed. Pro-inflammatory programmes are damped down and anti-inflammatory ones turned up. Over days, eosinophil numbers in the airway wall fall, the leaky vessels calm down, oedema recedes, and goblet cells stop overproducing. There is no immediate bronchodilation at all. Measurable improvement takes days; the full benefit takes weeks. This is why it is called a preventer.

Toggle both drugs in the animation and watch the difference in behaviour. The reliever moves the muscle ring within seconds of model time. The steroid does nothing at first, then slowly thins the wall and clears the mucus over what the readout labels as days.

Which leads to the most important self-check in asthma. How often you reach for the reliever is a measurement of how badly the controller is doing its job. Needing a rescue inhaler more than twice a week — leaving aside deliberate use before exercise — is a recognised signal of poor control. So is getting through canisters quickly: guidelines flag three or more reliever canisters a year as a marker of increased risk of a serious attack, and very heavy use (a canister a month or more) is associated with the highest risk of all, including death. Someone whose reliever is "working brilliantly, I use it all the time" is describing an emergency in slow motion, not good control.

Guidance has shifted decisively on this. Global asthma guidelines no longer recommend treating adults and adolescents with a reliever alone; every such patient should be on treatment that contains an inhaled corticosteroid, either taken regularly or combined with formoterol in a single inhaler used as the reliever itself — so that every time the airway complains, it receives anti-inflammatory treatment as well as bronchodilation. If you are still on a blue inhaler and nothing else, that is worth a conversation.

Myth: louder wheezing means a worse attack

This is the myth that kills, and it is worth being blunt about.

A wheeze is a sound made by air moving fast through a narrowed tube, setting the airway walls fluttering. It needs two ingredients: narrowing, and enough airflow to vibrate it. Take away the narrowing and the wheeze stops because there is nothing to vibrate. Take away the airflow and the wheeze also stops — and that is the terrifying version.

So wheeze intensity does not rise steadily with severity. It rises, peaks somewhere in the moderate range, and then falls again as obstruction becomes extreme and there is simply not enough air moving to make a noise. A chest that has gone quiet in a patient who is visibly struggling, sitting forward, unable to finish a sentence, using their neck and shoulder muscles to breathe, is showing a silent chest — and a silent chest is one of the classic signs of life-threatening asthma. It is a call-an-ambulance sign, not a reassuring one.

The animation makes this explicit. Move from Late phase to Severe and watch the wheeze meter fall while the radius, the peak flow, the oxygen saturation and the resistance all get dramatically worse. The silent-chest badge appears at the point where the sound is disappearing for the wrong reason.

The corollary is that a loud, musical, everybody-can-hear-it wheeze in someone who is talking in full sentences and moving plenty of air is usually the less alarming presentation. Judge severity by how the person is working — speech, posture, accessory muscle use, alertness — and by the numbers, never by the volume.

Myth: the steroid inhaler is the "strong" version of the rescue inhaler

People reach for this logic constantly, and it is completely understandable: steroids sound powerful, the reliever is not working, therefore take the powerful one. In an acute attack this reasoning is backwards.

An inhaled corticosteroid does essentially nothing in the next five minutes. It cannot relax smooth muscle, because it does not act on smooth muscle at all — it acts on gene transcription, which takes hours to change protein levels and days to change the cellular makeup of the airway wall. Puffing extra steroid during an attack while the reliever fails is not escalating treatment; it is losing time.

The reverse mistake is just as common and just as costly. Because the reliever produces an instant, obvious, gratifying effect and the steroid produces no felt sensation whatsoever, enormous numbers of people quietly stop the steroid and keep the reliever. Adherence to inhaled corticosteroids is notoriously poor, often well under half of prescribed doses. From the inside it feels rational — you are dropping the drug you cannot feel and keeping the one you can. From the airway's point of view you have deleted the only treatment that was reducing your risk of ending up in hospital, and kept the one that masks the symptom.

Two honest caveats so this is not misread. First, oral or intravenous steroids are different: systemic steroids are a standard part of treating a moderate-to-severe attack, and they matter — but they work over hours, not minutes, and they are given alongside, not instead of, bronchodilators and oxygen. Second, in the modern combination-inhaler approach, an ICS–formoterol inhaler can be used as a reliever — but that is because formoterol is a fast-onset bronchodilator that happens to be packaged with the steroid, not because the steroid became fast. The bronchodilator is still doing the acute work.

What sets an attack off

Triggers differ enormously between individuals, and part of living well with asthma is learning your own list rather than everyone else's. The common ones:

• Allergens — house dust mite, cat and dog dander, cockroach, tree and grass pollen, and moulds such as Alternaria and Aspergillus. These drive the IgE-mediated early-and-late-phase pattern the animation models.
• Viral respiratory infections — the most common trigger of exacerbations overall, and overwhelmingly the leading one in children. Rhinovirus is the usual culprit. The seasonal spike in childhood asthma admissions shortly after schools return each autumn is a real and well-documented phenomenon.
• Cold, dry air and exercise. Rapid breathing of cold dry air dries and cools the airway lining; the resulting change in the fluid's osmolarity provokes mast cells and epithelium to release mediators, and the airway constricts. This is exercise-induced bronchoconstriction, and its signature is that it typically peaks after exercise stops, often five to fifteen minutes later, rather than during it. It is far more common in cold, dry conditions than in warm humid air, which is one reason swimming is often better tolerated than winter running. Press the cold-air button in the animation to add this on top of any other scenario.
• Irritants — tobacco smoke (including second-hand), wood smoke, traffic pollution, strong fragrances, cleaning sprays, chlorine. These are not allergic reactions; they act on airway nerves and epithelium directly.
• NSAIDs in aspirin-exacerbated respiratory disease (AERD). A distinct subgroup — roughly one in twenty adults with asthma, and more among those with severe disease — has the triad of asthma, recurrent nasal polyps, and reactions to aspirin and other NSAIDs. The mechanism is elegant and worth knowing: these drugs inhibit COX-1, which shunts arachidonic acid down the 5-lipoxygenase pathway instead, flooding the airway with the same cysteinyl leukotrienes the mast cells release in an allergic attack. Reactions can be severe. If you have asthma with nasal polyps and a poor sense of smell, this diagnosis is worth raising with your clinician before your next headache tablet.
• Reflux (GERD). Acid reaching the lower oesophagus can trigger a vagal reflex that constricts airways, and microaspiration can irritate them directly. Reflux is a common comorbidity that aggravates asthma; treating it helps some people considerably and others not at all.
• Other common aggravators — strong emotion and laughter (via changes in breathing pattern), certain drugs including non-selective beta-blockers, thunderstorms during pollen season, and, for many women, the days before menstruation.

When an attack is an emergency

Asthma deaths are, in the great majority of cases, considered preventable — and national reviews repeatedly find the same failures: under-treatment with preventers, over-reliance on relievers, and delay in seeking help. Knowing the red flags matters.

Call emergency services if any of these appear:

1. The reliever is not working, or its effect is wearing off within a couple of hours.
2. Too breathless to speak in full sentences, to eat, or to sleep — single-word answers are a serious sign.
3. Peak flow in the red zone (below 50%) of personal best and not improving after the reliever.
4. A silent chest, or a wheeze that fades while the person visibly struggles.
5. Using accessory muscles — neck and shoulder muscles pulling with each breath, ribs and the notch above the breastbone drawing in, sitting hunched forward and gripping the knees (the tripod position).
6. Blue or grey lips, tongue, face or fingertips.
7. Drowsiness, confusion, exhaustion or agitation. In an attack this rarely means the person is calming down; it usually means carbon dioxide is rising and they are tiring.
8. Oxygen saturation below about 92% on a pulse oximeter.

One counterintuitive point that clinicians treat as a serious warning: during an attack people breathe fast, which normally blows carbon dioxide down. So a blood gas showing a normal or rising CO₂ in someone in the middle of a severe attack is ominous — it means the respiratory muscles are failing to keep up. A "reassuringly normal" number in the wrong context is not reassuring.

Note too that oxygen saturation is a late warning in asthma, not an early one. Look again at the animation: in the allergen scenario the resistance readout has already climbed many-fold and peak flow has fallen into the yellow zone while SpO₂ is still sitting in the mid-nineties. A normal oximeter reading does not mean an airway is fine — the lung compensates well right up until it does not.

Finally, the boring advice that actually works: have a written asthma action plan agreed with your clinician, know your personal best peak flow, take the preventer even on days you feel completely well, get the inhaler technique checked (a large fraction of people use theirs incorrectly, and a spacer fixes much of it), and treat every trip to the yellow zone as information rather than bad luck.

↑ Back to the animation

Connections

• All Interactive Visualizations
• Asthma — full topic page
• COPD — obstruction that does not reverse
• Pulmonology — all lung conditions
• Allergy & Pain Conditions
• Immunology
• Histamine, Mast Cells & Allergy
• Anaphylaxis & the EpiPen
• The Inflammation Cascade
• Mucociliary Escalator & the Cough Reflex
• Breathing & Gas Exchange
• Lung Surfactant